Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

A long-awaited study of septic shock treatments has found that expensive and risky parts of a widely accepted resuscitation protocol now in place in many hospitals do not improve outcomes when ...

Of all the life-threatening conditions hospitals battle on a daily basis, sepsis is a particularly fickle beast. Despite the difficulties associated with diagnosing this complication, healthcare ...

Sepsis, a common and potentially deadly complication to an infection, is the leading cause of death in U.S. hospitals, accounting for 35% of in-hospital deaths. But as many as 87% of sepsis cases ...

Inotrem and Roche’s diagnostics division have upgraded their years-long collaboration on a plasma test for septic shock, with a new worldwide licensing agreement. The France-based Inotrem secured the ...

SYDNEY--(BUSINESS WIRE)--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced an international patent application aimed at protecting the use of experimental ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Prolonged infusion of beta-lactam antibiotics for sepsis or septic shock tended to improve mortality compared with conventional intermittent infusion in the BLING III trial, and a meta-analysis ...

Patients with heart failure frequently suffer from fluid overload, and for those with heart failure with reduced ejection fraction (HFrEF) also suffering from septic shock—a condition often treated ...

The incidence of sepsis (and death from septic shock) is increasing, and treatments are still inadequate. Now a study in Science offers promise for a new treatment option involving blockade of ...

Please provide your email address to receive an email when new articles are posted on . The 30-day mortality benefit of sepsis antibiotic treatment within 3 hours was larger in some patient ...

Craig Lilly, MD, a pulmonary medicine and critical care specialist at the University of Massachusetts Memorial Medical Center, who was not one of the trial results authors, reacted to the study. "This ...